Bailard, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.86 - $3.36 $106,764 - $192,864	-57,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $62,320 - $156,620	41,000 Added 250.0%	57,400 $196,000
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $43,624 - $56,908	16,400 New	16,400 $49,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.